AGL 38.89 Increased By ▲ 0.87 (2.29%)
AIRLINK 206.39 Increased By ▲ 9.03 (4.58%)
BOP 9.64 Increased By ▲ 0.10 (1.05%)
CNERGY 6.30 Increased By ▲ 0.39 (6.6%)
DCL 9.10 Increased By ▲ 0.28 (3.17%)
DFML 37.85 Increased By ▲ 2.11 (5.9%)
DGKC 98.10 Increased By ▲ 1.24 (1.28%)
FCCL 35.72 Increased By ▲ 0.47 (1.33%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.85 Increased By ▲ 0.68 (5.16%)
HUBC 130.00 Increased By ▲ 2.45 (1.92%)
HUMNL 13.61 Increased By ▲ 0.11 (0.81%)
KEL 5.48 Increased By ▲ 0.16 (3.01%)
KOSM 7.31 Increased By ▲ 0.31 (4.43%)
MLCF 44.95 Increased By ▲ 0.25 (0.56%)
NBP 60.75 Decreased By ▼ -0.67 (-1.09%)
OGDC 221.00 Increased By ▲ 6.33 (2.95%)
PAEL 40.95 Increased By ▲ 2.16 (5.57%)
PIBTL 8.52 Increased By ▲ 0.27 (3.27%)
PPL 199.00 Increased By ▲ 5.92 (3.07%)
PRL 39.80 Increased By ▲ 1.14 (2.95%)
PTC 27.32 Increased By ▲ 1.52 (5.89%)
SEARL 108.05 Increased By ▲ 4.45 (4.3%)
TELE 8.61 Increased By ▲ 0.31 (3.73%)
TOMCL 36.05 Increased By ▲ 1.05 (3%)
TPLP 13.76 Increased By ▲ 0.46 (3.46%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 33.23 Increased By ▲ 0.26 (0.79%)
WTL 1.68 Increased By ▲ 0.08 (5%)
BR100 11,996 Increased By 269.5 (2.3%)
BR30 37,173 Increased By 796.8 (2.19%)
KSE100 112,475 Increased By 2961.9 (2.7%)
KSE30 35,481 Increased By 968.1 (2.8%)
World

Brazil regulator says Bharat Biotech vaccine does not meet factory standards

  • The Brazilian government signed a contract last month to buy 20 million doses of the Indian drugmaker's vaccine. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.
Published March 30, 2021

SAO PAULO: Brazilian health regulator Anvisa said Bharat Biotech's Covaxin COVID-19 does not meet its manufacturing standards, according to a note in the Tuesday edition of the official gazette.

The Brazilian government signed a contract last month to buy 20 million doses of the Indian drugmaker's vaccine. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.

Comments

Comments are closed.